A better
path to
clear
vision
Bringing simpler retinal care solutions to millions in need
////////////////  Innovating Patient-focused Retinal Care
invest
20
40
H
V
Z
D
S
20
40
N
C
V
K
D
20
40
C
P
B
T
N
20
40
I
-
0
1
C
20
40
T
I
R
N
S
20
40
Z
K
O
S
V
For decades, injections into the eye have remained the primary way of treating retinal vascular diseases.
INTRAVITREAL INJECTIONS
Injections, though effective, require patients to endure frequent and often uncomfortable appointments, wasting time and money.

Millions struggle with blurred vision caused by retinal conditions where there are no effective non-invasive treatments.

making eye drops a first-line treatment

/
PB-01
an engineered solution
PB-01 treats the Retina
PB-01 is our pioneering eye drop formula proven to deliver targeted treatment directly to the retina — a non-invasive approach that could change the standard of care for millions.
with in-depth research and experience, we're paving a new path in retinal care.
Our work is dedicated to exploring a solution to make treatment of retinal vascular diseases simpler, more accessible, and patient-centered.

INNOVATING patient-focused solutions to make eye health simpler for everyone

MEET THE FOUNDING TEAM
Saad Ahmad, MD
Founder & CEO
Dr. Saad Ahmad, MD, is a vitreoretinal surgeon with over 16 years of post-training clinical experience and over 30 years of scientific research experience.  Trained in the medical practice of Ophthalmology at Duke University and Washington University in St. Louis, he has also published and presented his research internationally.  Having received research funding from Research to Prevent Blindness, he has spearheaded and served as Principal Investigator for numerous clinical trials, as well as innovated several novel therapeutic approaches.  He has served in an executive and advisory capacity for a variety of medical and pharmaceutical companies.  
Edward Yavitz, MD
Co-Founder & CMO
Dr. Edward Yavitz, MD, is a practicing ophthalmologist who has specialized in cataract, glaucoma, corneal transplantation and LASIK surgeryfor more than 40 years.  He completed his education at Harvard University.  Dr. Yavitz was among the first to be certified to perform LASIK surgery by the American College of Eye Surgeons, and has chaired National sessions on refractive surgery.  He holds 50 US Patents for treating macular degeneration, myopia, glaucoma, and low vision. Additionally, he has taught surgical techniques to eye surgeons all over the world.